Sherbrooke, QC, Canada
Biotechnology · DeepTech · Health
1 - 10 employees
TATUM bioscience is a synthetic biology startup developing a new class of drug called synthetic live biotherapeutics (synLBT). synLBT are probiotics engineered to execute advanced therapeutic tasks. This technology disrupts the conventional drug development process by allowing us to build drugs instead of discovering them. Using its unique modular platform, TATUM design synLBTs to tackle diseases for which conventional drugs have now reached their limits .Something looks off?